Disclosure of risks and uncertainties are especially vital in light of regenerative medicine
Am J Bioeth
.
2014;14(4):14-6.
doi: 10.1080/15265161.2014.889244.
Authors
S L Niemansburg
1
,
M G J L Habets
,
J J M van Delden
,
A L Bredenoord
Affiliation
1
a University Medical Center Utrecht.
PMID:
24730482
DOI:
10.1080/15265161.2014.889244
No abstract available
Publication types
Comment
MeSH terms
Cause of Death*
Clinical Trials as Topic / ethics*
Humans
Informed Consent / ethics*
Moral Obligations*
Research Personnel / ethics*
Therapeutic Equipoise*
Truth Disclosure / ethics*